Homepage
Author:
Sixty Degrees Pharmaceuticals
Posted Date:
April 15, 2026
60 Degrees Pharma Announces ARAKODA (tafenoquine) for Malaria Prevention is Now Available on Runway Health Travel Website
Sixty Degrees Pharmaceuticals
April 15, 2026
60 Degrees Pharmaceuticals Announces 2025 Annual Results
Sixty Degrees Pharmaceuticals
March 31, 2026
60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (NDIN) with FDA for Australian Chestnut Extract
Sixty Degrees Pharmaceuticals
March 18, 2026
60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial
Sixty Degrees Pharmaceuticals
March 11, 2026
60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership
Sixty Degrees Pharmaceuticals
February 2, 2026
60 Degrees Pharmaceuticals Exercises License Option with Florida State University for Large-Scale Purification of Castanospermine for Non-Rx Use
Sixty Degrees Pharmaceuticals
January 28, 2026
60 Degrees Pharmaceuticals Announces Partnership with Runway Health to Provide International Travelers Direct Access to ARAKODA® for Malaria Prevention
Sixty Degrees Pharmaceuticals
January 27, 2026
